BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6382676)

  • 1. Early results of cardiac transplantation at the Texas Heart Institute.
    Reece IJ; Frazier OH; Painvin A; Okereke OJ; Chandler LB; Krudewig TW; Cooley DA
    Thorax; 1984 Sep; 39(9):676-80. PubMed ID: 6382676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present expectations in cardiac transplantation.
    Baumgartner WA; Augustine S; Borkon AM; Gardner TJ; Reitz BA
    Ann Thorac Surg; 1987 Jun; 43(6):585-90. PubMed ID: 3296975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac transplantation at the Texas Heart Institute: comparative analysis of two groups of patients (1968-1969 and 1982-1983).
    Frazier OH; Cooley DA; Painvin GA; Chandler LB; Okereke OU
    Ann Thorac Surg; 1985 Apr; 39(4):303-7. PubMed ID: 3885882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac transplantation with cyclosporin A and prednisone.
    Griffith BP; Hardesty RL; Deeb GM; Starzl TE; Bahnson HT
    Ann Surg; 1982 Sep; 196(3):324-9. PubMed ID: 7051996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation.
    Olivari MT; Kubo SH; Braunlin EA; Bolman RM; Ring WS
    Circulation; 1990 Nov; 82(5 Suppl):IV276-80. PubMed ID: 2225416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Powerful but limited immunosuppression for cardiac transplantation with cyclosporins and low-dose steroid.
    Griffith BP; Hardesty RL; Bahnson HT
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):35-42. PubMed ID: 6361393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart transplantation in females.
    Esmore D; Keogh A; Spratt P; Jones B; Chang V
    J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection and infection after pediatric cardiac transplantation.
    Braunlin EA; Canter CE; Olivari MT; Ring WS; Spray TL; Bolman RM
    Ann Thorac Surg; 1990 Mar; 49(3):385-90. PubMed ID: 2178568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced infection in cardiac transplant recipients.
    Dresdale AR; Drusin RE; Lamb J; Smith CR; Reemtsma K; Rose EA
    Circulation; 1985 Sep; 72(3 Pt 2):II237-40. PubMed ID: 3896557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cardiac transplant rejection without massive immunosuppression.
    Michler RE; Smith CR; Drusin RE; Reison DS; Hickey TJ; Lamb J; Reemtsma K; Rose EA
    Circulation; 1986 Nov; 74(5 Pt 2):III68-71. PubMed ID: 3533317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of recalcitrant cardiac allograft rejection with methotrexate.
    Costanzo-Nordin MR; Grusk BB; Silver MA; Sobotka PA; Winters GL; O'Connell JB; Pifarré R; Robinson JA
    Circulation; 1988 Nov; 78(5 Pt 2):III47-57. PubMed ID: 3052918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac transplant patient at one year. Cyclosporine vs conventional immunosuppression.
    Emery RW; Cork R; Christensen R; Levinson MM; Icenogle TB; Riley J; Ott RA; Copeland JG
    Chest; 1986 Jul; 90(1):29-33. PubMed ID: 3522120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospective randomized trial.
    Esmore DS; Spratt PM; Keogh AM; Chang VP
    J Heart Transplant; 1989; 8(3):194-9. PubMed ID: 2661768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-term results of heart transplantation in diabetic patients.
    Livi U; Caforio AL; Grassi G; Boffa GM; Gambino A; Milano A; Bianco R; Casula R; Thiene G; Casarotto D
    J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):115-8. PubMed ID: 7775522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
    J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted blood levels of cyclosporin for cardiac transplantation.
    Griffith BP; Hardesty RL; Trento A; Lee A; Bahnson HT
    J Thorac Cardiovasc Surg; 1984 Dec; 88(6):952-7. PubMed ID: 6389991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart transplantation.
    Levett JM; Karp RB
    Surg Clin North Am; 1985 Jun; 65(3):613-35. PubMed ID: 3898433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation.
    Barr ML; Sanchez JA; Seche LA; Schulman LL; Smith CR; Rose EA
    Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.